NCT07580157
A Study Of Focused Shockwave For Anterior Knee Pain Following Anterior Cruciate Ligament Reconstruction
Enrolling by Invitation
NAAges 18+InterventionalTreatmentMayo ClinicInvestigator-initiated
~20 participants
Updated 2026-05-12 on ClinicalTrials.gov
What's tested:Focused ShockwaveSham Focused Shockwave
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in International Knee Documentation Committee (IKDC) Subjective Knee Evaluation score
Measured over Baseline, 7 days, 14 days, 21 days, 6 months, 9 months, and 12 months
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Joshua M. Romero, M.D. · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Adults ≥18 years of age.
Have undergone primary ACL-R with BTB or QT autograft.
Have not previously undergone FSW or radial pressure wave (RPW) in the past for any indication
Must speak English
Capacity to provide consent
Exclusion
Pregnant or breastfeeding.
Revision ACL-R.
History of previous ipsilateral knee surgery.
Multi-ligament knee injury requiring surgical intervention beyond ACL.
History of deep vein thrombosis.
Active infection at or near the harvest site.
What this trial measures
- Change in International Knee Documentation Committee (IKDC) Subjective Knee Evaluation scoreBaseline, 7 days, 14 days, 21 days, 6 months, 9 months, and 12 months
The International Knee Documentation Committee (IKDC) Subjective Knee Evaluation is a patient-reported outcome measure focusing on knee symptoms, function, and sports activity. It is scored on a 0-100 scale, where higher scores indicate higher function and lower symptoms.